(Q45042022)

8 December 2017

title

HLA-A2 expression, stage, and survival in colorectal cancer (English)

1 reference

8 December 2017

1 reference

3

Carmen Scheibenbogen

1 reference

8 December 2017

Philipp Kiewe

1

1 reference

8 December 2017

Veit Mansmann

2

1 reference

8 December 2017

Heinz-Johannes Buhr

4

1 reference

8 December 2017

Eckhard Thiel

5

1 reference

8 December 2017

Dirk Nagorsen

6

1 reference

8 December 2017

publication date

7 May 2008

1 reference

International Journal of Colorectal Disease

8 December 2017

published in

1 reference

8 December 2017

volume

23

1 reference

8 December 2017

issue

8

1 reference

8 December 2017

page(s)

767-772

1 reference

Gender differences in long-term survival of patients with colorectal cancer

8 December 2017

cites work

1 reference

12 December 2020

DNA typing of HLA class I (HLA-A) and class II genes (HLA-DR, -DQ and -DP) in Japanese patients with gastric cancer

1 reference

12 December 2020

Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients

1 reference

12 December 2020

The prognostic factors of stage IV colorectal cancer and assessment of proper treatment according to the patient's status

1 reference

12 December 2020

Gastric cancer and human leukocyte antigen: distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori

1 reference

12 December 2020

Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients

1 reference

12 December 2020

HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor.

1 reference

12 December 2020

MHC-peptide specificity and T-cell epitope mapping: where immunotherapy starts.

1 reference

12 December 2020

The anatomical substrate for a difference in surgical approach to rectal cancer in male and female patients

1 reference

12 December 2020

HLA-class II haplotype associations with ovarian cancer.

1 reference

12 December 2020

Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years

1 reference

12 December 2020

Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis

1 reference

12 December 2020

Male gender adversely affects survival following surgery for colorectal cancer

1 reference

12 December 2020

Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results

1 reference

12 December 2020

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

12 December 2020

HLA polymorphisms are associated with Helicobacter pylori infected gastric cancer in a high risk population, China

1 reference

12 December 2020

Rational peptide-based tumour vaccine development and T cell monitoring

1 reference

12 December 2020

Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan

1 reference

12 December 2020

Human leukocyte antigen and esophageal cancer in the northwestern region of Iran

1 reference

12 December 2020

Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population.

1 reference

12 December 2020

Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer.

1 reference

12 December 2020

Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer

1 reference

12 December 2020

HLA-B8 association with late-stage melanoma--an immunological lesson?

1 reference

12 December 2020

10.1007/S00384-008-0488-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

1037197155

0 references

1 reference